You searched for "EMR"
Embedding EMR for a complete transformation in user experience
1 August 2016
| Rod McNeil
|
EYE - General
Informatics and IT projects in the NHS have a history of being over budget, delivered late and not fulfilling the design brief. “But it doesn’t have to be that way,” believes Chris Canning, Consultant Ophthalmologist and Chief Clinical Information Officer...
Specialty-driven EMR for paperless clinical environment – insights for an informed choice
1 August 2016
| Rod McNeil
|
EYE - General
Deployment of specialty-driven (or specialty-specific) electronic medical record (EMR) systems across UK ophthalmology units appears to be growing rapidly at the expense of generic, multiuse digital technology packages. Experience further suggests that open source systems can play a significant role...
PRN Ranibizumab verses continuous aflibercept in UK clinical practice
1 October 2018
| Jonathan Chan
|
Retina / Uvea / Vitreous
|
Age related macular degeneration, aflibercept, anti-VEGF therapy, ranibizumab
This was a multicentre (21 UK hospitals), national EMR study on treatment naïve nAMD eyes, undergoing predominantly as needed (PRN) Ranibizumab or continuous (fixed or treat and extend - (F/TE)) Aflibercept (Af). The primary outcome was change in vision at...
Interview with Clinical Director of OpenEyes
1 April 2015
| David Haider
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Professor James Morgan is an Ophthalmic Consultant at Cardiff Hospital and also the clinical director of the OpenEyes programme. Given the national push for electronic records we felt hearing directly from James would be of interest. The interview was conducted...
Electrocautery and implantable cardiac devices
This is a literature review of the risks associated with bipolar and monopolar electrocautery in patients with a permanent pacemaker (PPM) or implantable cardioverter defibrillator (ICD). The authors found 12 publications which met their inclusion criteria, but within these there...
Proptosis reduction with teprotumumab versus surgical decompression
This study aims to explore whether fat-to-muscle ratio (FMR) can be used to determine the efficacy of teprotumumab when compared to surgical decompression. Simply put, a high FMR equates to more fat expansion and low FMR equates to more muscle...Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice
1 February 2015
| Pearse A Keane (Prof), Adnan Tufail
|
EYE - Vitreo-Retinal
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...
Effective contrast ratio as a measure of binocular visual perception
2 February 2024
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
The authors used a binocular phase combination paradigm to quantitatively evaluate and compare the binocular visual perception of normal individuals and patients with different types of strabismus to understand the binocular visual perception of patients with strabismus and evaluate whether...
Pentacam vs. IOL Master keratometry measurement in IOL power calculations
1 June 2014
| Anjali Gupta
|
Ophthalmology
|
IOL Master keratometry, Pentacam, Scheimpflug, equivalent keratometry reading
The IOL Master measures only the anterior corneal curvature and estimates the total corneal power by assuming a fixed relationship between the anterior and posterior corneal surface. The Pentacam measures both the anterior and posterior corneal surface and therefore calculates...
Charles Bonnet Syndrome: Life in isolation
29 April 2020
|
COVID-19
Judith Potts, the founder of Esme's Umbrella, which is the campaign to raise awareness of Charles Bonnet Syndrome and to source founding into research.
A paperless future – get involved!
1 August 2014
| David Haider
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Jeremy Hunt’s statement earlier in 2014, about a paperless NHS by 2018, has added momentum to the transition away from paper records. The Tech Review this issue discusses what that will involve and how and why you may want to...
Mastering Monovision with Professor Graham Barrett and Mr Alastair Stuart
21 March 2025
|
Company Profiles, Research & Development
Professor Graham Barrett, creator of RayOne EMV, joins Mr Alastair Stuart, Medical Director of Optegra UK, to discuss why he frequently selects this lens for patients in Rayner’s Peer2Peer podcast series. Mr Stuart shares insights on patient selection, calculations, and...
